A Chinese drugmaker with close military ties is seeking fast-track approval for a drug that it says can cure Ebola as China joins the race to help treat a deadly outbreak of the disease, which has spread from Africa to the United States and Europe.
Sihuan Pharmaceutical Holdings Group Ltd. signed a tie-up with Chinese research Academy of Military Medical Sciences last week to help push the drug, called JK-05, through the approval process in China and bring it to market.
The drug, developed by the academy, is currently approved for emergency military use only.